07.30.18
The Trump administration (the Administration) has called for a reduction in drug spending.
07.19.18
In the late 1990s, healthcare providers began prescribing opioids at greater rates to treat chronic pain.
02.27.18
Over the past five years, the budgets of state Medicaid programs have been challenged by the introduction of new high-cost drugs into the marketplace.
02.21.18
There are six key drivers of the movement to a risk-based healthcare environment:
10.11.17
On September 8, 2017, Massachusetts submitted a waiver amendment request to the Centers for Medicare & Medicaid Services (CMS) to modify its MassHealth Section 1115 demonstration.
12.19.16
Gene therapy is the therapeutic delivery of polymers into a patient’s cells for the purpose of treating a disease. Polymers interfere with gene expression or correct mutations.
06.22.16
In its April 25, 2016 Medicaid managed care final rule, the Centers for Medicare and Medicaid Services (CMS) provides a revised framework for determining how managed care plans should be paid by state Medicaid programs.
06.16.16
In its April 25, 2016 Medicaid managed care final rule, the Centers for Medicare and Medicaid Services (CMS) addresses a core issue: how managed care plans should be paid by state Medicaid programs.
04.26.16
There are a few different steps that organizations can and should be taking to prepare for a possible audit. The first is that there should be an internal gap analysis conducted of the organization's HIPAA compliance program. The analysis should include comparing the organization's existing ...
09.24.15
As the legal landscape in healthcare becomes increasingly complex, healthcare companies that receive federal program funds face increasing exposure under the federal False Claims Act (FCA), 31 U.S.C. §§ 3729–3733.